Mechanobiological Design of Bioinspired Polymeric Scaffolds for Bone Regeneration

Hematoma and early inflammatory response

The bone repair process initiates immediately following fracture, where the disruption of blood vessels results in hematoma formation. ⁹ This fibrin-rich clot acts as a temporary scaffold, recruiting hematopoietic and mesenchymal stem cells (MSCs) via local and systemic circulation. ¹⁰ In addition to initiating inflammation and releasing proinflammatory mediators, this phase represents the earliest stage of mechanical sensing. ¹¹ Mechanical instability, specifically interfragmentary shear or compression, directly affects early ECM formation. For instance, a recent study by Mehl revealed that externally applied shear across a fracture gap delayed hematoma remodeling and altered the morphology of early collagen fiber orientations and microvascular networks, independent of the YAP/TAZ signaling pathway. ¹² These findings indicate that mechanical boundary conditions are detected at the very outset of healing and can bias subsequent tissue organization before callus formation.

Callus formation and strain-dependent differentiation

As the hematoma evolves into granulation tissue, progenitor cells differentiate into osteogenic lineages, ¹³ a process modulated by soluble factors like bone morphogenetic proteins (BMPs), stromal cell-derived factor-1 (SDF-1), ¹⁴ and hypoxia-inducible factor-1α (HIF-1α). ¹⁵ Importantly, the mechanical history of the defect site strongly influences this differentiation. Mehta et al. demonstrated that interfragmentary strain patterns present during the early soft callus phase (less than 2 weeks) accurately predicted the geometry and patterning of the callus at later stages. ¹⁶

The transition from soft cartilaginous callus to hard bony callus is governed by specific mechanical thresholds, as described by foundational mechanobiological theories.

Cellular mechanotransduction and vascular adaptation

At the cellular level, mechanical signals are transduced into biological responses that drive tissue remodeling. ²¹ MSCs exhibit extreme sensitivity to tissue-level elasticity, specifying lineage commitment based on substrate stiffness. ²² Research by Mao verified that substrate stiffness regulates osteogenesis in MSCs, ²³ while Winer et al. showed that MSCs on soft substrates exhibit decreased proliferative activity compared to those on stiffer surfaces. ²⁴ These findings underscore the importance of scaffold substrate stiffness as a primary determinant of MSC fate, providing a direct rationale for tuning polymeric scaffold elasticity in bone tissue engineering.

Crucially, vascularization—a prerequisite for osteogenesis—is also mechanically regulated. Vascular networks are highly sensitive to mechanical conditions.^25,26 For example, skeletal fatigue loading has been shown to induce a rapid increase in periosteal vascularity. ²⁷ Recent mechanistic studies reveal that mechanical forces trigger the mechanoreceptor PIEZO1, which modulates the transformation of Type H vessels into Type L vessels to coordinate bone growth with mineralization. ²⁸ Conversely, the stiffness of the scaffold or ECM regulates microvascular stability; stiff ECM enhances endothelial cell integrin phosphorylation and Connective Tissue Growth Factor production, thereby promoting the differentiation of pericytes into myofibroblasts. ²⁹ Furthermore, the timing of mechanical stability is critical: in a large bone defect model, early mechanical loading was found to inhibit vascular invasion, whereas late mechanical loading (after 4 weeks of stiff fixation) significantly stimulated vascular remodeling. ²⁶ Together, these observations suggest that scaffold mechanics must be tuned not only in magnitude but also in timing to support both angiogenesis and osteogenesis.

Finite element analysis and microstructural characterization

In the context of bone tissue engineering, finite element analysis (FEA) has evolved into an indispensable tool for estimating bone mechanics and predicting scaffold performance. Increasingly, FEA is applied beyond whole-bone models to micro-FE (µFE) simulations of scaffolds within defect sites, enabling the precise prediction of local strain and fluid flow at the scaffold–host interface. ³² By linking imaging-derived microstructures to apparent mechanical competence, these models provide a robust quantitative framework for evaluating novel biomaterials and architectures. ³³

Currently, high-resolution µFE, derived from microcomputed tomography (µCT), serves as the in vitro and ex vivo reference standard for correlating trabecular architecture with stiffness and failure modes. ³⁴ However, the intrinsic porosity and heterogeneity of trabecular bone make these models highly sensitive to boundary conditions and material assignments, which can skew mechanical estimations. ³⁵ Translating these microstructural insights to the clinic relies heavily on High-Resolution Peripheral Quantitative CT (HR-pQCT). In vivo, HR-pQCT successfully quantifies site-specific mechanical competence at peripheral sites (e.g., radius or tibia), directly linking microarchitectural metrics to clinical outcomes like fragility fractures. ³⁶ Yet, its inability to fully capture the mechanics of larger, load-bearing bones remains a significant clinical bottleneck.

To overcome the limitations of conventional morphometry ³⁷ and reduce the computational burden of high-resolution models, voxel-based continuum approaches have gained traction. These methods can predict trabecular bone modulus directly from clinical CT images without the need for explicit segmentation. ³⁸ Furthermore, as demonstrated by Oefner et al., µCT-derived morphology can effectively estimate anisotropic elastic properties in osteoporotic bone, offering critical biomechanical insights for interventions such as spinal instrumentation. ³⁹ While these continuum approaches successfully reduce preprocessing complexity, a fundamental challenge remains: their predictive accuracy is still heavily constrained by available imaging resolution and underlying assumptions of tissue homogeneity.

Computational efficiency, platform accessibility, and homogenization strategies

Despite the predictive power of high-resolution FEA, its widespread utility is frequently bottlenecked by the immense computational overhead required to model large, highly porous scaffold-host architectures. Currently, commercial simulation platforms such as Abaqus (Dassault Systèmes) and ANSYS remain the industry standards for high-fidelity bone biomechanics. ³² While these platforms provide robust, user-friendly multiscale modeling environments, their prohibitive licensing fees present a significant barrier to routine clinical integration. ⁴⁰ Consequently, open-source solvers like FEBio have emerged as vital alternatives. FEBio offers powerful biphasic and multiphasic modeling capabilities at no software cost, ⁴¹ though its effective implementation often demands a steeper learning curve and advanced computational expertise. ⁴²

Beyond software accessibility, the feasibility of FEA is heavily dictated by hardware constraints, forcing researchers to navigate the trade-off between model fidelity and computational efficiency. Voxel-based continuum FEA, derived directly from high-resolution micro-CT, provides unparalleled anatomical accuracy but requires massive memory allocation. Processing these patient-specific models typically exceeds the capacity of standard desktop environments, necessitating reliance on high-performance computing clusters or cloud infrastructure to solve the millions of degrees of freedom generated by the highly complex porous network. ⁴³ To circumvent these hardware limitations, the field is increasingly exploring homogenized or reduced-order hybrid FE strategies. Techniques such as the Firm and Floppy Boundary Lattice Element Method offer simplified approximations that can be efficiently solved on standard computational hardware. ⁴⁴ While homogenization sacrifices localized microstructural detail, it provides a highly pragmatic solution for rapid, large-scale biomechanical screening.

Emerging frontiers: Multiscale modeling and machine learning

Recent modeling efforts extend beyond linear elastic stiffness to capture aspects of bone remodeling. Multiscale frameworks increasingly couple organ-level loading (e.g., musculoskeletal simulations) with tissue-level adaptation algorithms, enabling more patient-specific analyses of how geometry or scaffold architecture may influence bone formation under physiological loads. ⁴⁵

Furthermore, to better capture crack initiation and age-related changes in toughness, newer computational formulations, such as phase-field approaches, are being employed. ⁴⁶ Machine learning (ML) is increasingly used to complement FEA. ML surrogates trained on FE outputs can approximate biomechanical quantities (e.g., stresses or failure risk) with substantially reduced computation time, facilitating rapid screening of design spaces. However, their performance depends strongly on the quality, representativeness, and size of the training datasets, and they currently lack the mechanistic transparency of physics-based models. ⁴⁷

Overall, computational tools are most effective when used in combination with experimental validation, rather than as stand-alone predictors of biological or clinical performance. These trade-offs in spatial resolution, computational burden, and clinical applicability are summarized in Table 1.

OPEN IN VIEWER

Table 1.

Comparison of Major Computational Modeling Modalities in Bone Tissue Engineering

Modeling modality	Primary application	Key advantages	Primary limitations	References
High-resolution micro-FE (µFE)	Trabecular microarchitecture and scaffold-host interface mechanics	Highest local mechanical fidelity; reference standard for microstructural analysis	Computationally intensive; highly sensitive to boundary conditions	34,35
Clinical HR-pQCT-based analysis	Peripheral in vivo bone-strength assessment	Strong clinical relevance; links microstructure to fracture-related outcomes	Limited anatomical coverage; less suitable for large load-bearing bones	36
Voxel-based continuum FEA	CT-based stiffness and modulus prediction	Faster preprocessing; does not require explicit segmentation	Dependent on imaging resolution and homogeneity assumptions	38,39
Homogenized/ reduced-order FE	Large-scale screening and scaffold design studies	Fast and computationally efficient	Misses local microstructural detail	44

CT, computed tomography; FE, finite element; FEA, finite element analysis; HR-pQCT, high-resolution peripheral quantitative CT.

Natural polymers

Prioritizing Bio-Recognition over Mechanics Natural organic polymers, including collagen, chitosan, and silk fibroin, are inherently hydrophilic and contain bioactive motifs that support cell attachment and differentiation. Chitosan, a derivative of chitin, is widely valued for its biodegradability and biocompatibility. However, its mechanical utility is constrained by pH-dependent solubility and relatively low stiffness. ⁵¹ Similarly, collagen, the primary organic component of bone ECM, provides an ideal osteoconductive surface ⁵² but lacks the compressive strength required for load-bearing defects. While silk fibroin offers improved handling and mechanical properties compared with collagen, its degradation rate is relatively slow. ⁵¹

To compensate for these mechanical limitations, natural polymers are frequently incorporated into composite systems. For instance, electrospun chitosan/polyethylene oxide nanofibers have been shown to support osteoblast attachment, ⁵³ while chitosan–gelatin scaffolds significantly enhanced structural properties and healing in rat critical-sized defects. ⁵⁴ Importantly, these examples illustrate that natural polymers are most effective when combined with reinforcing phases or architectures that improve load-bearing capacity. Chitosan/nanohydroxyapatite composites have demonstrated superior proliferative responses in rabbit tibial defects, ⁵⁵ and collagen-HAp scaffolds have been shown to commit human MSCs toward osteogenic lineages in vitro ⁵⁶ and induce spontaneous mineralization in vivo.^57,58 Furthermore, crosslinking collagen with chitosan creates tubular scaffolds with desirable porosity and pliability, mimicking the mechanical properties of blood vessels and enhancing nerve affinity.^59,60

From a manufacturing perspective, most natural polymer scaffolds are produced by freeze-drying, electrospinning, or hydrogel-based processing. These methods are effective for generating highly porous architectures, but they often suffer from variability in pore size, source-dependent raw material quality, and crosslinking-dependent mechanical performance, which complicate batch standardization and large-scale production. Although natural polymers offer excellent biological recognition and accessible sourcing, their clinical translation is often hindered by batch-to-batch variability, rigorous purification demands, limited shelf life, and the necessity for secondary crosslinking or composite reinforcement to achieve adequate mechanical strength. ⁶¹

Synthetic polymers

Tunable Elasticity and Structural Guidance Synthetic biodegradable polymers, including polylactic acid (PLA), polyglycolic acid (PGA), and poly(lactic-co-glycolic acid) (PLGA), offer superior control over mechanical properties. Their processability and tunable elasticity enable fabrication of structures capable of bearing clinically relevant loads. ⁵¹ However, their hydrophobic surfaces often hinder initial cell attachment, and their degradation rates can be difficult to control in vivo, potentially leading to autocatalytic acidic environments. ⁶²

In contrast, synthetic polymers are generally more compatible with scalable manufacturing workflows, including melt processing, solvent casting/particulate leaching, electrospinning, and additive manufacturing. Their greater industrial processability is a translational advantage, although this benefit must be balanced against hydrophobicity, acidic degradation products, and the difficulty of simultaneously achieving high porosity and bone-matched mechanics.

From a mechanobiological perspective, the architecture of synthetic scaffolds is as critical as their chemistry. Electrospinning has emerged as a key technology for producing nanofibrous scaffolds that mimic the hierarchical structure of the ECM. ⁶³ The alignment of these fibers provides contact guidance cues that direct cell fate. For example, Rowland et al. demonstrated that aligned polydioxanone scaffolds supported greater adipogenic and osteogenic differentiation of MSCs compared to random orientations or PLGA counterparts. ⁶⁴ Further reinforcing synthetic matrices with ceramics, such as PLA/HAp composites, has been shown to upregulate BMP-2 and osteopontin expression, ⁶⁵ while Poly(ε-caprolactone) (PCL)/PLGA composites have successfully induced Alkaline phosphatase (ALP) and Collagen-1 expression in rabbit models. ⁶⁶ Together, these studies suggest that mechanical reinforcement combined with bioactive additives is necessary to translate synthetic polymers toward effective bone regeneration. Conversely, while synthetic polymers offer superior industrial scalability and batch reproducibility for large-scale manufacturing, their overall translational cost-effectiveness is often compromised by the need for surface modifications, composite reinforcement, and the clinical management of acidic degradation byproducts. ⁶⁷

Inorganic and composite systems

Mimicking the Native Stiffness Profile To fully replicate natural bone—a composite of organic collagen and inorganic apatite—scaffolds must integrate multiple phases. Inorganic polymers, such as biocalcite, bio-polyphosphate (bio-polyP), and bio-silica, have been identified as potent metabolic modulators. Bio-silica substrates stimulate osteogenic activity and BMP-2 expression, ⁶⁸ while bio-polyP induces hydroxyapatite formation and inhibits osteoclastogenesis.^69,70

In practice, the most effective strategies involve composite materials in which polymers are reinforced with ceramics (e.g., calcium phosphate, bioglass),^71–73 silicon, ⁷⁴ or nanomaterials ⁷⁵ to better approximate the stiffness of native bone.

Ceramic Reinforcement: Hydroxyapatite (HAp) is the standard for osteoconductivity. Incorporating HAp into chitosan ⁷⁶ or collagen scaffolds ⁵⁷ significantly enhances matrix deposition compared with polymer-only controls. ⁷⁷ Although β-tricalcium phosphate (β-TCP) resorbs 10–20 times faster than HAp, its brittleness often limits its use in high-load regions. ⁷⁸

Nanomaterial Reinforcement: Nanomaterials like carbon nanotubes, graphene, and nanohydroxyapatite offer exceptional mechanical strength and high surface-area-to-volume ratios. ⁷⁵ Rather than being used in isolation, these nanomaterials are most effective when integrated into hierarchical composite designs.

For example, our group developed a mineralized collagen-glycosaminoglycan (MC-GAG) scaffold via coprecipitation, creating a nanoparticulate mineralized content that mimics native bone composition.^79,80 Mechanistically, these MC-GAG scaffolds induce MSC osteogenesis and constitutive Smad1/5 phosphorylation independent of exogenous BMP-2, ⁸¹ autogenously activating the BMP signaling pathway in vivo. ⁷² This work illustrates how nanoscale mineral organization, rather than bulk stiffness alone, can critically influence osteoinductivity. Composite systems introduce an additional level of fabrication complexity because mineral phase, polymer phase, pore architecture, and crosslinking conditions must all be controlled simultaneously. For example, MC-GAG scaffolds are fabricated through coprecipitation/mineralization followed by freeze-drying and crosslinking, enabling control over calcium phosphate content, pore size, and scaffold stiffness but also requiring tight process control to ensure homogeneous mineral distribution and reproducible mechanical properties across batches. Although composite scaffolds offer superior biological and mechanical matching, their clinical translation is often complicated by the need to simultaneously control multiple structural phases during manufacturing, which inherently increases production costs, quality control demands, and the difficulty of industrial scale-up. ⁶⁷

Functionalization for signaling and delivery

Beyond structural mechanics, scaffolds act as vehicles for biochemical and genetic cues.

Clinical tolerance and host response

While optimizing the mechanobiological properties of scaffolds is a prerequisite for bone tissue engineering, successful clinical translation ultimately hinges on host tolerance and the mitigation of adverse immune responses. The nature of this host response is intrinsically linked to the biomaterial’s origin. Natural polymers, such as collagen and chitosan, are celebrated for their innate biocompatibility and bioactivity; however, their clinical application is frequently complicated by risks of immunogenicity and pathogen transmission if sourced from allogeneic or xenogeneic tissues without exhaustive purification. ⁸⁷ Furthermore, when these natural matrices are utilized as nonviral gene delivery platforms—such as those incorporating PEI-pDNA complexes—they have been documented to provoke prolonged localized inflammatory cascades and cytotoxic responses. ⁸⁸

In contrast, synthetic aliphatic polyesters (e.g., PLA, PGA, and their copolymer PLGA) circumvent the risks associated with xenogeneic sourcing, yet they introduce distinct clinical challenges dictated by their degradation profiles. These polymers degrade in vivo primarily via bulk hydrolysis, releasing acidic monomers such as lactic and glycolic acid. If the localized accumulation of these acidic byproducts outpaces the surrounding tissue’s buffering capacity, it induces an autocatalytic degradation cycle. ⁸⁹ Clinically, this localized acidic microenvironment can precipitate a robust sterile inflammatory response, characterized by foreign body giant cell recruitment, delayed-onset osteolysis, and exacerbated bone resorption—all of which severely compromise the structural integrity of the regenerating site. ⁹⁰ Consequently, a critical design imperative for both synthetic and composite scaffolds is the precise calibration of degradation rates to align with the host’s metabolic clearance capabilities, thereby preventing acidic accumulation and subsequent postoperative complications. ⁹⁰

4D printing and spatiotemporal adaptation

The concept of “4D printing” extends additive manufacturing by introducing time as the fourth dimension. ⁹¹ These systems utilize shape-memory polymers and stimulus-responsive composites to undergo programmable changes in shape or property in response to physiological triggers such as temperature, hydration, or pH. Systematic reviews highlight that these adaptive architectures can enable minimally invasive deployment and improved conformity to irregular defects without compromising baseline physiomechanical properties compared to static controls.^91–93

From a mechanobiological perspective, the principal advantage of 4D systems is their potential to better align scaffold geometry and mechanics with the evolving state of the healing tissue. However, the majority of studies remain proof-of-concept, and long-term in vivo performance, reproducibility, and manufacturing scalability are not yet well established.

Beyond shape change, mechanically adaptive hydrogels represent a significant leap forward. In these systems, stiffness and viscoelasticity are engineered to evolve spatiotemporally, matching the mechanical stiffening of the callus during the reparative phase. Several groups have coupled these materials with finite element modeling to guide mechanical design, but standardized metrics for comparing “mechanical adaptivity” across platforms are still lacking. ⁹⁴

A generic translational workflow integrating clinical assessment, FE-guided design, and adaptive scaffold fabrication is shown in Figure 3. In this generic scheme, patient-specific imaging is first processed via FEA to map the local mechanical environment and determine optimal strain thresholds. These computational outputs directly inform the geometric design and material selection of shape-memory or stimuli-responsive polymers. Following 4D fabrication, the scaffold is deployed via minimally invasive techniques, where physiological triggers (e.g., body temperature or pH) activate its spatiotemporal adaptation. This closed-loop approach ensures the scaffold not only fills the defect but also dynamically shifts its mechanical profile to match the evolving stiffness of the native healing callus.

OPEN IN VIEWER

FIG. 3.

Generic treatment workflow for mechanobiology-guided scaffold design in bone regeneration. The proposed workflow integrates clinical assessment, imaging-based defect characterization, finite element (FE)-guided structural optimization, and advanced fabrication into a unified translational pathway. Following patient-specific evaluation of defect geometry, anatomical site, fixation requirements, and host bone quality, imaging data are used to reconstruct the local mechanical environment. FE modeling then predicts strain, stress, and fluid-flow distributions to define mechanically permissive design targets for scaffold architecture, porosity, degradation profile, and material composition. These outputs inform fabrication of a patient adapted scaffold, including 4D-printed systems with time-dependent or stimulus-responsive behavior. After implantation, scaffold performance is shaped by fixation mechanics and the evolving stages of repair, including hematoma formation, callus development, and remodeling. Longitudinal follow-up data can then be fed back into future model refinement and design optimization, enabling a closed-loop strategy for scaffold translation.

Mechanoelectrical transduction: Piezoelectric scaffolds

Recognizing that bone is an inherently piezoelectric tissue, researchers are developing biomaterials that convert daily mechanical loading into local electrical stimulation. These bioelectrical signals are thought to influence ion flux, focal adhesion dynamics, and mechanosensitive pathways (e.g., Yes-associated protein [YAP]/Transcriptional co-activator with PDZ-binding motif [TAZ]), although the precise in vivo dose–response relationships remain incompletely defined. ⁹⁵

Recent translational work has focused on piezoelectric polymer composites, particularly poly(vinylidene fluoride)-based systems reinforced with osteogenic phases like hydroxyapatite (HAp) or barium titanate (BaTiO₃). These composites have demonstrated accelerated bone repair in vivo by effectively integrating electrical cues with microtopographical guidance. Mechanistic studies further clarify this effect; for instance, a mechanically tunable fiber-reinforced hydrogel was recently reported to enhance bone repair specifically through the PIEZO1–integrin axis, illustrating how scaffold mechanics and biochemical modulation can be coordinated to sustain osteogenic mechanotransduction. ⁹⁶ Nevertheless, challenges remain regarding material fatigue under cyclic loading, long-term biocompatibility, and reproducible electrical output in clinically relevant environments.

Data-driven design and closed-loop optimization

Optimizing scaffold microarchitecture—balancing porosity, topology (e.g., triply periodic minimal surface, TPMS), anisotropy, and degradation—remains challenging using purely empirical approaches. As a result, data-driven methods are increasingly being explored. In emerging closed-loop workflows, ML models are trained on experimental or simulated datasets to predict mechanical or biological responses and to suggest candidate architectures that better meet predefined performance criteria.^97,98 Importantly, these approaches are most effective when constrained by mechanobiological principles rather than used as purely black-box optimizers. Their generalizability depends on dataset quality, representativeness, and consistency of experimental assays.

Looking forward, integrating mechanobiology-informed descriptors (e.g., predicted strain/strain-rate fields, fluid shear, and electrical potentials) with experimental datasets may further improve generalizability and reduce trial-and-error, especially when coupled to mechanistic simulation (FEA) and standardized reporting.^94,99 However, translation of ML-guided designs to clinically manufacturable and regulatory-compliant scaffolds remains a substantial hurdle.